| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 3,225,264 | 3,270,597 | 3,657,857 | 3,605,073 | | Cost of Revenue | 2,315,002 | 2,441,475 | 2,633,416 | 2,621,557 | | | Gross Profit | 910,262 | 829,122 | 1,024,441 | 983,516 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 970,719 | 993,011 | 1,020,551 | 986,918 | | Non Recurring |
-
| 1,484,964 |
-
|
-
| | Others |
-
| 5,619 | (1,873) | (1,873) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (60,457) | (1,654,472) | 5,763 | (1,529) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,365) | 8,810 | 5,482 | 12,106 | | Earnings Before Interest And Taxes | (62,822) | (1,645,662) | 11,245 | 10,577 | | Interest Expense | 17,918 | 22,655 | 16,405 | 14,406 | | Income Before Tax | (80,740) | (1,668,317) | (5,160) | (3,829) | | Income Tax Expense | (25,408) | (129,306) | 1,538 | (1,827) | | Minority Interest | 593 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (54,739) | (1,539,011) | (6,698) | (2,002) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (54,739) | (1,539,011) | (6,698) | (2,002) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($54,739) | ($1,539,011) | ($6,698) | ($2,002) |
|
0.45% Nasdaq 
0.20%
Income Statement
